NEOPLASMS BY SITE
Clinical trials for NEOPLASMS BY SITE explained in plain language.
Never miss a new study
Get alerted when new NEOPLASMS BY SITE trials appear
Sign up with your email to follow new studies for NEOPLASMS BY SITE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Targeted drug trial aims to outperform chemo for tough lung cancer
Disease control TerminatedThis study compared a new targeted drug called pralsetinib against standard chemotherapy for people with advanced lung cancer that has spread and carries a specific genetic change called a RET fusion. The trial involved 223 participants worldwide who had not yet received treatmen…
Matched conditions: NEOPLASMS BY SITE
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New targeted cancer drug tested in patients who ran out of options
Disease control TerminatedThis early-stage study tested a new targeted cancer drug called EO-3021 in adults with advanced stomach and other digestive cancers that had stopped responding to standard treatments. The main goal was to find a safe dose and see if the drug caused tumors to shrink. The study was…
Matched conditions: NEOPLASMS BY SITE
Phase: PHASE1 • Sponsor: Elevation Oncology • Aim: Disease control
Last updated Mar 19, 2026 14:55 UTC
-
Terminated trial tests Last-Chance drugs for tough kidney cancers
Disease control TerminatedThis study tested two different drug combinations for people with advanced kidney cancer that had stopped responding to standard treatments. The trial aimed to find safe doses and see if these combinations could shrink tumors or slow disease progression. The study was terminated …
Matched conditions: NEOPLASMS BY SITE
Phase: PHASE2 • Sponsor: NiKang Therapeutics, Inc. • Aim: Disease control
Last updated Mar 18, 2026 14:40 UTC